Addressing obesity through the clinical trials of anti-obesity drugs requires innovative, patient-centered approaches. In this webinar, the speakers will provide insights improving obesity clinical trial outcomes, with a focus on strategies to maximize patient retention. Additionally, this webinar will highlight the importance of endpoint protection to ensure the integrity and reliability of the trial’s results.
Register for this webinar today to learn how maximizing patient retention and protecting endpoint integrity are making a significant impact on the success of obesity clinical trials.
1. https://doi.org/10.1016/S0140-6736(23)02750-2
Join experts from Medpace, Jennifer Brown, Sr. Director, Clinical Trial Management; Amanda Sylvester, DNP, APRN, CPNP-BC, Advanced Clinical Practitioner; and Prudence King, MSN, APRN, AGPCNP-BC, Advanced Clinical Practitioner, for the live webinar on Thursday, August 22, 2024, at 10am EDT (4pm CEST/EU-Central).
For more information, or to register for this event, visit Revolutionizing Obesity Clinical Trials: A Patient-Centric Approach.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], www.xtalks.com
SOURCE Xtalks
